Updated Jul 16, 2026
Sukhtian Ghiath M. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $5.00M.

Sukhtian Ghiath M. is identified in SEC filings connected to Outlook Therapeutics, Inc. dated around 2026-06-02. The available context indicates an insider or executive association with the company, but the filings do not provide a complete public biography or confirm an exact title. Based on the SEC context, the individual appears relevant to the governance or leadership of Outlook Therapeutics, Inc., though broader biographical details are not disclosed in the provided materials.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | OTLK | Outlook Therapeutics, Inc. | P — Open-market purchase | 8.54M | $0.59 | $5.00M |
Sukhtian Ghiath M. is identified in SEC filings connected to Outlook Therapeutics, Inc. dated around 2026-06-02. The available context indicates an insider or executive association with the company, but the filings do not provide a complete public biography or confirm an exact title. Based on the SEC context, the individual appears relevant to the governance or leadership of Ou…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 4 open-market purchases ($5.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sukhtian Ghiath M. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.